Biotechnology
CYTRX CP [CYTR] +12.90%
INTROGEN THERAPEU [INGN] +10.95%
SENESCO TECH [SNT] +10.37%
IDERA PHARMACEUTICAL [IDP] +10.00%
CYTORI THERAPEUTICS [CYTX] +9.26%
Diagnostic Substances
INFINITY PHARMACEUTI [INFI] +5.07%
IMMUNOMEDICS INC [IMMU] +4.62%
ORCHID CELLMARK INC [ORCH] +4.16%
BIOSITE INC [BSTE] +4.02%
IMMUCOR INC [BLUD] +3.70%
Drug Delivery
ALKERMES INC [ALKS] +8.47%
BIOPROGRESS PLC [BPRG] +5.87%
NEKTAR THERAPEUTIC [NKTR] +4.66%
GENEREX BIOTECH CORP [GNBT] +4.65%
COLUMBIA LABS INC [CBRX] +3.90%
Drug Manufacturers
NITROMED, INC. [NTMD] +19.67%
TELIK INC [TELK] +10.40%
QUICK-MED TECHNOLOG [QMDT.OB] +8.11%
EXEGENICS INC [EXEG.OB] +6.92%
ALLOS THERAPEUTICS [ALTH] +6.03%
Medical Appliances & Equipment
SIGNALIFE INC [SGN] +16.00%
HANSEN MEDICAL, INC. [HNSN] +7.89%
VNUS MEDICAL TECHNOL [VNUS] +7.59%
CAMBRIDGE HEART INC [CAMH.OB] +6.42%
SIRONA DENTAL SYS [SIRO] +5.99%
Medical Instruments & Supplies
MILESTONE SCIENTIFIC [MLSS.OB] +20.00%
IVAX DIAGNOSTICS INC [IVD] +9.73%
MESA LABS INC [MLAB] +9.47%
ENDOLOGIX INC [ELGX] +6.16%
HOME DIAGNOSTICS, IN [HDIX] +5.75%
Medical Laboratories & Research
MEDASORB TECHNOLOGS [MSBT.OB] +14.48%
NEOGENOMICS INC [NGNM.OB] +4.85%
ARRAY BIOPHARMA IN [ARRY] +4.25%
BIO-IMAGING TECH [BITI] +3.23%
NATL DENTEX CP [NADX] +2.62%
http://www.biohealthinvestor.com/
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
